SILO PHARMA, INC. Increase (Decrease) in Other Accounts Payable
SILO PHARMA, INC. (SILO) had Increase (Decrease) in Other Accounts Payable of $185.00 thousand as of 2025-05-31, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2026-08-13
- 2025-05-31: Increase (Decrease) in Other Accounts Payable $185.00K.
- 2024-06-28: Increase (Decrease) in Other Accounts Payable $197.40K.
| Period end | Increase (Decrease) in Other Accounts Payable |
|---|---|
| 2025-05-31 | $185.00K 10-Q · filed 2025-11-13 |
| 2024-06-28 | $197.40K 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |